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Bioactive glasses (BGs) are amorphous bioactive materials
that were first reported by Hench (Hench, 2006 ; Hench et
al. , 1971 ; Hench & Paschall, 1973). The components of
BGs can be classified into network formers (NFs), network
modifiers (NMs), and intermediate oxides ( IOs) (Brauer,
2015) Figure 1 illustrates the general BG structure. NFs are
components that form a glass network without the involve-
ment of other materials by forming tetrahedra and oxygen
triangles ; they include B2O3, SiO2, GeO2, P2O5, As2O3, Sb2O3,
In2O3, Ti2O3, SnO2, PbO2, and SeO2 (Lakes, 2003). Of these,
the most widely studied are silica (SiO2), boron trioxide (B2
O3), and phosphorous pentoxide (P2O5) (Brauer, 2015). NMs
can change glass structure by creating terminal oxygens
called nonbridging oxygen atoms (NBOs) breaking down the
glass network, some of the most common are CaO, Na2O,
SrO, B2O3, P2O5, etc. While IOs are the components able to
function as NMs or NFs depending on the glass composition
the most common are MgO and Al2O3 (Brauer, 2015).
BGs have a three−dimensional (3D) tetrahedral network
structure in which an NF is linked with oxygen atoms via
four covalent bonds ; these are known as bridging oxygen
atoms (BOs) (Brauer, 2015 ; Hupa & Karlson, 2017). An
NM changes the structure by forming ionic bonds with oxy-
gen, thereby changing BOs into NBOs (Brauer, 2015 ; Hupa
& Karlson, 2017) (figure 2). BG properties depend on the
extent of bonds with NBOs and BOs.
There are many possibilities to classify the glasses, in this
review, they are classified according to their composition
system.
Types of Bioactive glasses based on the net-
work formers
a. Silicate−based glasses
Silica is the NF in silicate−based BGs. Silicate−based
BGs were first discovered by Hench in the late 1960s and
are the most widely studied for bone regeneration systems
and drug carriers due to the high valence of silicon. Silicate
−based BGs have a tetrahedral structure (Figure 3a) with
BOs, NBOs.
Their bioactivity, surface area, porosity, and pore size
make silicate−based BGs particularly interesting for scaf-
folds and grafts. Nevertheless, some of their mechanical
properties are insufficient for clinical application (Hench and
Jones, 2015).
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Abstract
Bioactive glasses (BGs) are biomaterials intended for
applications including hard−tissue regeneration (ortho-
pedics, dentistry, and maxillofacial areas ) , coatings,
wound healing, and drug delivery. Network formers
(NFs), network modifiers (NMs), and intermediate ox-
ides (IOs) play key roles in the in vitro and in vivo
performances of BGs. Understanding the influence of
BG NMs on dissolution rate, hydroxycarbonate apatite
layer formation, and therapeutic activity is fundamental
to the development of new BGs. Generic BGs designed
by dipping in several active ions have been proposed.
This review provides an overview of the effects of
NMs (e.g., strontium, magnesium, zinc, and copper) on
BG properties and characteristics. Understanding the ef-
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Figure 1 : Schematic representation of bioactive glass components. a) network former (NF), b) net-
work modifier (NM), c) bridging oxygen atoms (BOs), and d) nonbridging oxygen atoms (NBOs).
Figure 2 : Schematic representation of bioactive glass network structure a) tetrahedral structure without
network modifiers and b) disruption of network by network modifier.
Figure 3 : Schematic representation of structure units that build up the silicate−(a), phosphate −(b), and borate− (c)
glasses network.
2 Enrique Ezra ZUÑIGA−HEREDIA et al.／Network modifiers of bioactive glasses : a review
（2）
第４０巻１号　　　４Ｃ１５０　１Ｃ１３３／本文　※３１‐１から組体裁変更　ＯＴＦ／００１～０１２　Ｒｅｖｉｅｗエンリケ４Ｃ  2021.07.06 18.30.27  Page 2 
b. Phosphate−based glasses
Phosphate−based BGs consist of an inorganic network of
phosphate (PO43– ) tetrahedra, connected to a maximum of
three other phosphate tetrahedra (figure 3b). Their synthesis
is more challenging because the P2O5 precursor is very un-
stable and requires metal ions for stabilization (Jones, 2013 ;
Skelton et al., 2007). The most used metal−oxides are Na2O
and CaO. The abilities of this class of glasses to completely
dissolve and control the dissolution rate merit considerable
interest (Deshmukh et al., 2020).
Phosphate−based BGs have applications in radiotherapy
(Sene et al., 2008), hard−tissue regeneration, drug delivery,
and wound healing (Mehrabi et al., 2020).
c. Borate−based glasses
Borate glasses comprise a network based on boron triox-
ide (B2O3). Their lower level of chemical stability results in
faster dissolution and transformation into a hydroxycarbon-
ate layer (HCA) (Deshmuck et al., 2020). HCA formation
occurs by a process similar to that of silicate− and phos-
phate−based BGs. In contrast to silicate and phosphate −
based glasses, the incorporation of modifier cations increases
the network connectivity due to a transformation from neu-
tral BO3 into a negatively BO4 balanced with the main cation
(Hupa et al., 2017) (figure 3c). These glasses have a phe-
nomenon called the “boron abnormally” referring to the no−
linear change in network connectivity, meaning that an in-
crease of oxide modifiers at some point increase the network
connectivity, but higher addition will convert back into
trigonal borate, decreasing the network connectivity (Hupa
et al., 2017). Borate BGs can support cell proliferation and
differentiation, exhibit high bioactivity (Lepry et al., 2015),
and control dissolution rate (Fu et al., 2010). However, bo-
rate ion toxicity is the main concern of borate−based BGs ;
some studies have noted that borate−based BGs are toxic in
“static” in vitro conditions but not in “dynamic” in vivo
conditions (Fu et al., 2010 ; Jung et al., 2012).
Bioactive glass’s structure
The structure of bioactive glass can be described in terms
of network connectivity ( NC ) . Network connectivity de-
scribes the short−range structure classified and represented
by Q n distribution, where Q symbolizes the network−form-
ing polyhedron, and n corresponds to the number of bridg-
ing oxygens atoms connected to each polyhedron of the
structure (0,1,2,3 and 4) Figure 4 schematically represent the
NC values for silicate−, phosphate−, and borate−based BGs.
The NC provides information concerning the degree of po-
lymerization and enables the prediction of glass characteris-
tics, such as crystallization tendency ( Hill et al. , 2011 ;
O’Donnell, 2011 ) , bioactivity ( Eden, 2011 ; Hill et al. ,
2011 ) , and polymerization ( Eden, 2011 ) . According to
Deshmuhk (2020), a higher value of NC indicates a more
connected network, although bioactivity properties diminish
at higher NC values (Inert products have an NC value of
Q 4). The desired value for good bioactivity is between Q 2
Figure 4 : Schematic representation of silicate−, phosphate−, and borate−based glasses structure unit in Qn..
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and Q 3, a decrease in these values will weaken the 3D struc-
ture due to the small amount of bridging oxygen atoms,
leading to easier disruption of the glass structure.
Since their discovery, many materials based on the origi-
nal BG composition have been synthesized and extensive re-
search has been conducted to understand their bioactivity
mechanisms ( Eden, 2011 ; Hench, 1991 ; 1998 ; 2015 ;
Hench & Polak, 2002 ; Hench et al., 2004 ; Hill et al., 2011 ;
Jones, 2013 ; O’Donnell, 2011).
BG bioactivity is strictly linked to partial dissolution of
the network and surface reactivity. Partial dissolution leads
to ion release and HCA layer formation on the surface. The
HCA layer bonds with hard and soft tissues (Hench, 1991 ;
1998 ; 2015 ; Hench & Polak, 2002 ; Hench et al. , 2004 ;
Jones, 2013 ; Vichery et al., 2016). Figure 5 describes the
mechanism of HCA layer formation.
Hitherto, the term “BG bioactivity” was exclusively used
in the context of the repair and regeneration of hard tissue
(Mehrabi et al., 2020). More recently, this concept has been
broadened with potential applications to soft−tissue regen-
eration, such as wound healing (Gillete et al., 2001), spinal
cord (Joo et al., 2012), muscle (Shah et al., 2005), and liga-
ment repair (Bitar et al., 2005), lung tissue engineering (Ver-
rier et al., 2004), gastrointestinal applications (Boccaccini et
al., 2005), cardiac tissue regeneration (Chen et al., 2020),
embolization of uterine fibroids (Kehoe et al., 2012), and
cancer treatment (Chauhan et al., 2019).
BGs can be synthesized by methods such as melt quench
(Hench et al., 1971), sol−gel (Deshmukh et al., 2020), sol−
gel with coprecipitation (Jones et al. , 2013), and sol−gel
with irradiation (Deshmukh et al., 2020). The use of wet
chemistry has provided a broader range of bioactive BGs
with unique morphologies, sizes, porosities, and composi-
tions (adding active ions) (Deshmukh et al., 2020).
The incorporation of active ions via intermediate oxides
(IOs) influences the crystallization, morphology, crystallin-
ity, solubility, thermal stability, and dissolution behavior of
BGs. These IOs are also known as doping agents (DAs) ;
they improve the mechanical characteristics of BGs and add
therapeutic effects, allowing DA−doped BGs to serve as ver-
satile tools for dentistry. Rigorous study and design of new
compositions and in vitro testing of existing compositions
are warranted.
Effect of doping agent on the bioactive glasses
During BGs synthesis, cationic DAs with ionic bonds to
NBOs function as NMs. Following network modification,
the dissolution rate changes according to the NC value (Fig-
ure 4). For the Q 1 case, the dissolution rate increases dra-
matically due to the weakness of the 3D BG structure. As
the value approaches Q 4, the dissolution rate, and bioactivity
decrease. Cations modify the internal structure and environ-
ment surrounding BGs particles. The size of each DA inter-
feres with the 3D structure (opening or closing the network
structure), thereby increasing or decreasing the glass dissolu-
tion rate. Table 1 proportionate a brief description of the DA
Figure 5 : Schematic illustration of hydroxycarbonate apatite layer formation on the surface of silica−based bioactive
glass.
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and its behavior in BGs. Overall, NM−doped BGs display a
wide range of therapeutic effects, and applying wet chemis-
try for structural modification has extended the types of bio-
active materials available. However, many challenges re-
main. Some of the most common DAs and their functions
are described below.
a. Boron
Boron Oxide (B2O3) is an NM that can also function as an
NF. The addition of boron increases the glass network con-
nectivity by forming 4−coordinates BO4. As an NM the in-
crease of boron has shown to decrease the specific surface
area, thus maybe related to the diminished contribution by
micropores blocking of the glass network. Therefore, the in-
crease of mechanical stability and bioactivity (Deilmann et
al., 2020). In vitro studies established that boron (B) was
toxic to cell cultures, but no toxicity was detected during in
vivo studies on rats (Fu et al., 2010 ; Jung et al., 2012). B−
doped BGs enhanced HCA layer formation (bioactivity), im-
proved the antibacterial effect, promoted cell proliferation
(human periodontal ligament cells ; Bai et al., 2020), and in-
creased alkaline phosphatase activity. Adding 2 mol% of B2
O3 to BGs enhanced biocompatibility with endothelial cells
(Haro Durand et al., 2014) and showed a pre−osteoblastic
cells (MC3T3−E1) inhibition of > 46.1% (Brown et al. ,
2009). Chang et al. (2020) used B−doped BGs as a compo-
nent for composite bone cement. They found direct relation-
ships of boron content with specific surface area, average
pore size and volume, and compressive strength. Zhang et
al. (2020) used 3D−printed borosilicates (in which the con-
centrations of B2O3 were 19.4 mol% and 38.8 mol%) and
sodium alginate implants for mandible reconstruction in
rats ; the borosilicates were almost fully degraded within 28
days. Moreover, they reported good mechanical properties,
excellent biocompatibility, and promotion of bone regenera-
tion. Notably, borosilicate spheres have been used to en-
hance lesion targeting and simulate temporary vascular oc-
clusion to treat conditions such as hemorrhages of hyper−
vascular tumors in pigs (Doucet et al., 2021).
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Strontium NM, IO
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Decrease HCA in high quantities
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Bauer et al., 2012
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Table 1 : Doping agents’ effects on bioactive glass network, cells, and tissues.
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b. Sodium
Sodium oxide (Na2O) is an NM that disrupts the silica
network by bonding with NBOs. Hench in 1971 noted that
sodium (Na) is critical for network dissolution and BG bio-
activity. However, high amounts of Na2O can produce hy-
groscopicity, which affects BG stability and mechanical
properties. Chen et al. (2017) demonstrated that Na is not
essential for BGs bioactivity. They compared Na−free BG
with high−Na−content (29.6 mol% and 28.3 mol%) BGs.
The Na−free BGs were highly bioactive. Crovace et al.
(2021) reported that substituting Na2O to K2O in BGs in-
creased the densification rate ; this was attributed to a higher
tendency to crystallize.
c. Magnesium
Magnesium (Mg) has important roles in muscle metabo-
lism and bone formation (Rath et al., 2014). The incorpora-
tion of magnesium into bioactive glasses takes place through
magnesium oxide (MgO). MgO can behave as an NF or
NM. As NM, reduces the bioactivity in−vitro due to a small
ionic radii making a more compact glass structure (Jodati et
al., 2020 and Azevedo et al., 2010). However, as NF, in-
crease the surface reactivity (bioactivity) and osteogenic ac-
tivity (osteoblast proliferation) due to the substitution of Si−
O−Si by Si−O−Mg which is weaker (Azevedo et al., 2010).
d. Phosphorous
Phosphorous pentoxide (P2O5) can behave as an NF or as
an NM, its role as NM, is very complex in BGs. Li et al.
(2021), confirmed that a high content of phosphate increased
the bioactivity and enhance the proliferation of cells (5.07
mol%) (Li et al. 2021), however more than 10 mol% phos-
phate content in a silica−based BG reportedly resulted in a
non−bioactive composition (Arcos et al., 2010).
e. Calcium
The calcium cation (Ca2+)plays a primary role in the for-
mation of hydroxyapatite, which is the main component of
the human body´s hard tissues (teeth and bones). It is found
throughout the human body and participates in various meta-
bolic processes. In bioactive glasses calcium is a typical
NM, it is added to BGs as calcium oxide (CaO). It is needed
to enhance the formation of an HCA layer. In the initial
phases of dissolution, Ca2+ deposits in the superficial layer of
BGs, forming Ca–PO clusters that eventually form an HCA
layer (Schumacher et al., 2021). Therefore, Ca2+ has a criti-
cal role in BG bioactivity.
f. Titanium
Titanium oxide (TiO2) is an IO that can function as an NF
or an NM according to its concentration in the glass. As NF,
it increases the glass crystallization temperature, because it is
incorporated as TiO2 into the glass structure (Geol et al. ,
2007). Titanium ion tetrahedrally coordinates with SiO2 and
BO. Mahdy et al. (2021), reported an increase in glass sta-
bility (i.e., reduced ion leaching) after doping 5% and 10%
of TiO2 into BGs (Mahdy et al., 2021). The stability was at-
tributed to the formation of a CaTiSiO5 phase (Deer et al.,
1992) and its incorporation as an NF. As an NM TiO2 en-
hances crystallization (Park et al., 2008) without changing
glass shape or morphology (Mahdy et al., 2021). Further-
more, in 2021 lung reported an increase of surface hardness
on titanium (Ti), silver (Ag), cobalt (Co) doped bioactive
glass coatings, maybe related that TiO2, CoO, and Ag nano-
particles could act as nano − filler particles ( Lung et al. ,
2021). The addition of 4% TiO2 reduces the rate of amor-
phous calcium phosphate (ACP) / HCA layer formation in
vitro, but in more physiological condition (adding of pro-
teins) an enhancement of HA formation was observed (Asif
et al., 2014). The good biocompatibility displayed by Ti−
doped BGs makes them suitable candidates for tissue regen-
eration (Mahdy et al., 2021).
g. Cobalt
Cobalt Oxide (CoO) as NM, delays the formation of the
HCA layer in a Co concentration−dependent manner. Lung
et al. (2021), used All56s a multi−ion−doped (Ti, Co, and
Ag) reporting enhanced angiogenesis and osteogenesis re-
lated to cobalt ion (Co2+). All56s BG showed good biocom-
patibility, which contrasts with the cytotoxicity detected in
MC3T3−E1 mouse osteoblast − like cells ( Fleury et al. ,
2006), and cell viability reduction of a line derived from os-
teosarcoma cells (MG63) due to oxidative stress (Chatto-
padhyay et al., 2015) by Co−doped BGs. The All56s multi−
ion BGs, synthesized by Lung et al. (2021), had greater anti-
bacterial activity against Porphyromonas gingivalis, com-
pared with individual ion−doped BGs (except Ag−doped
BGs).
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h. Copper
Copper (Cu) is an essential element in collagen synthesis,
which plays a crucial role in bone formation and healing. In-
terest to use Copper Oxide as an NM is based on its abilities
to stimulate angiogenesis and osteogenesis ( Miola et al. ,
2014). An in vitro study of 1.5 mol% CuO in BGs found
inhibition of S . aureus growth, highlighting the potential of
the material to avoid post−surgical infections and enhance
hard−tissue regeneration (Akhtach et al., 2021). El−Fiqi et
al. (2021), studied a nano−delivery system based on Cu−
doped BGs loaded with epidermal growth factor. The system
displayed angiogenic and antibacterial effects toward Entero-
coccus faecalis . Moreover, epidermal growth factor − Cu −
doped BGs produced a regenerative effect on human dental
pulp stem cells. The introduction of CuO in BGs with dif-
ferent compositions had no negative effect on bioactivity.
However, dose−dependent cytotoxicity toward 3T3 fibro-
blasts was observed at copper ion (Cu2+) concentrations > 10
mg/L for biocomposites of Cu−doped BGs and nanofibril-
lated cellulose used for wound−healing applications. The an-
tibacterial, angiogenic, and osteogenic properties of Cu −
doped BGs make them potentially suitable materials for or-
thopedic and dental applications (Wang et al., 2016).
i. Zinc
Zinc (Zn) is needed for the formation of bones in the hu-
man body. It plays a role in bone metabolism and has anti-
bacterial effects (Balasubramanian et al., 2015). ZnO is an
excellent stabilizer, improving glass properties, and is an ex-
cellent biocide. It can function as an NF or NM. As an NM,
it reduces the surface area and pore size of BGs because its
ionic radii is smaller than that of Ca2+, which results in a
more compact and tightly bonded glass network, increasing
the strength of glass, thus decreasing their solubility (Anand
et al., 2014). Miola et al. (2014), found that the precipitation
of crystalline hydroxyapatite from a highly Zn−doped (20
mol%) BG only occurred after 1 month of immersion in
simulated body fluid. Other authors confirmed that the intro-
duction of ZnO reduced the solubility and leaching rate of
ions, thereby delaying hydroxycarbonate layer formation
(Aina et al., 2009 ; Lusvardi, 2009 ; Oudadesse et al., 2011).
Esteban−Tejeda et al. (2015), evaluated the effect of ZnO
content in BGs on Escherichia coli and Staphylococcus
aureus, which revealed that Zn2+ could be attached to micro-
organism membranes via electrostatic forces. Hence, Zn2+
could trigger membrane electrochemical potential to provoke
cell death. The biocidal activity was directly related to Zn
content.
j. Strontium
Strontium (Sr) is a bone−seeking element (similar to cal-
cium). In the human body, is found in the skeleton (98%),
liver, muscles, and sites of high metabolic turnover
(D’Haese et al., 1997 ; Dahl et al. , 2001). Strontium can
function as NM, incorporated into the glass as strontium ox-
ide (SrO). Strontium ions (Sr 2+) upregulate osteoblast activ-
ity (enhancing bone formation) and downregulates osteoclast
activity (inhibiting resorption) (Mao et al. , 2017). Brauer
(2012) demonstrated the antibacterial effect of Sr upon in-
jection into bone defects to stabilize the bone structure. The
feasibility of Sr2+ as a substitute for Ca2+ in hydroxyapatite
has increased interest in Sr−doped BGs. Furthermore, Sr−
doped bioactive glasses are “highly appealing for treatment
of bone pathologies” (Mao et al., 2017).
Sr−doped BGs enhance the HCA layer formation due to
the larger size of Sr2+ , compared with Ca2+ ( Wei et al. ,
2014). The expanded BG network displays improved bioac-
tivity (Taherkhani et al., 2016). However, if the percentage
is increased over 10% of Sr content, the HCA layer forma-
tion is inhibited due to Sr2+ inhibition of octacalcium−phos-
phate formation (Wei et al., 2014). Additionally, the release
of Sr2+ from BGs stimulates osteogenic differentiation in
bone marrow mesenchymal stem cells (Mosqueira et al. ,
2021). These studies are consistent with the findings of Fei
et al. (2021), who showed that the optimal concentration of
Sr could enhance bioactivity and osteoblast activity. Fiorilli
et al. (2021) found that Sr−doped BGs functionalized with
ICOS−Fc decreased bone resorption (Fiorilli et al., 2021).
k. Silver
Silver (Ag) is an IO and NM. Ag−doped BGs display
bactericidal and bacteriostatic properties. The bactericidal ef-
fect of silver ion (Ag+) results from its interaction with the
cell membrane (altering membrane permeability), its inhibi-
tion of adenosine triphosphate production ( disrupting cell
protein and enzyme synthesis), and interference in DNA rep-
lication. The antibacterial effect of Ag−doped BGs has been
evaluated in Gram−positive and Gram−negative bacterias,
including E. coli and S. aureus (Kazemian et al., 2021 ; Zhu
et al., 2014).
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Kazemian et al. (2021), synthesized Ag−doped BGs that
formed an HCA layer after one day of immersion in simu-
lated body fluid. Their procedure improved the bioactivity,
compared with a previous study where an HCA layer
formed only after three days of immersion (El−Rashidy et
al., 2018). Additionally, Kazemian et al. (2021), observed
good biocompatibility of Ag−doped BGs below a concentra-
tion of 250 μg/mL. These results are consistent with the
findings of Zhu et al. (2014), that Ag−doped BGs were a
good matrix for osteoblast growth. Ag−doped BGs are thus
a promising material for bone regeneration.
l. Cerium
Cerium (Ce) is a rare earth element also of interest as a
BG dopant. It promotes bone formation (positive effect in
vitro toward mouse osteoblasts ; Zhang et al., 2010) and is
effective as an implant coating (Li et al., 2018). The behav-
ior of Ce as a neuroprotective agent is related to its antioxi-
dant activity (Schubert et al., 2006). The antioxidant prop-
erty derives from its ability to quench free radicals by
switching between Ce4+ and Ce3+ and adjusting the oxygen
saturation of its microenvironment. Ce induces anti−inflam-
matory effects, enhances osteogenesis, and angiogenesis
(Celardo et al. , 2011 ; Li et al. , 2018 ; Mahapatra et al. ,
2017 ; Nethi et al., 2017). Ce doped in BGs does not affect
the morphology or structure of BG particles (Atkinson et al.,
2019). Zheng et al. (2020), synthesized Ce−mesoporous BG
nanoparticles, which were noncytotoxic in vitro , and down-
regulated the expression levels of pro−inflammatory genes
(IL−1β, IL−6, and TNF−α) and oxidative stress−related
genes (NOS2 and MMP9) in macrophages. Ce−doped BGs
had a higher gene expression level of OPG than RANKL,
suggesting improved osteogenesis. Ce−doped BGs were in-
corporated into electrospin chitosan/polyethylene oxide nano
−fiber scaffolds for use in soft−tissue engineering. However,
increasing the Ce content led to nanoparticle agglomeration ;
and wettability was reduced when the content exceeded 10
wt.% (Saatchi et al., 2021).
Concluding remarks and challenges regarding
bioactive glasses
Hench suggested that the era of innovation in BGs spans
the period 2005–2025, during which time a wide range of
gene−targeting BGs would be developed. However, many
challenges must be addressed before the clinical use of BGs
(Hench et al., 2015). A notable frontier involves the material
−based guidance of stem cells. More rigorous studies are
needed concerning the interference of ions in the upregula-
tion and downregulation of genes before gene−targeting BGs
can reach clinical applications.
Immediate challenges for BGs involve improvement of
mechanical properties ; development of reliable coatings, soft
−tissue engineering applications, interfacial tissue engineer-
ing applications, reliable in vitro and in vivo testing method-
ologies ; and controlled release of therapeutic ions and bio-
molecules (Baino et al., 2018).
In dentistry, BGs have been used primarily for enamel
remineralization, as a coating, and bone regeneration
(Kawaguchi et al., 2017). However, novel approaches with
new bioactive formulations and modifications are needed be-
fore clinically approved products are manufactured.
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